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Four new substituted dithiocarbazate ligands [S-napthalen-2-ylmethyl-
dithiocarbazate (SNMDTC), S-quinolin-2-ylmethyl-dithiocarbazate (SQ2MDTC), S-
benzyl-N-benzyldithiocarbazate (SBNBDTC) and S-methyl-N-benzyldithiocarbazate 
(SMNBDTC)], eight series of isomeric Schiff bases derived from different types of 
S-substituted dithiocarbazate and their metal complexes were successfully 
synthesized and characterized. Eighteen structures were determined using single 
crystal X-ray diffraction analysis. These newly synthesized compounds were 
systematically designed to form structurally heterogeneous compounds for QSAR 
study. 
 
Schiff bases were derived from condensation of isomeric aldehydes and ketones, 3- 
and 4-methylacetophenone and 2-, 3- and 4-acetylpyridine with different substituted 
dithiocarbazate compounds. Upon complexation, all Schiff bases formed bis-
 iv
chelated (NS donor) complexes except for the uninegative tridentate, S-napthalen-
2yl methyl-β-N-(2-acetylpyridine)dithiocarbazate (SNM2AP) that coordinated with 
metal ions via the azomethine nitrogen atom, the pyridyl nitrogen atom and the 
thiolo sulfur (NNS donor) 
 
Some of these newly synthesized compounds exhibited significant activities towards 
selective strains of pathogens and marked cytotoxicity when assayed against breast 
cancer estrogen receptor positive, MCF-7 and breast cancer estrogen receptor 
negative, MDA-MB-231 cell lines. The biological activities of the isomeric Schiff 
bases and their complexes were investigated. Most of the complexes exhibited 
higher activity compared to their parent ligands upon complexation with metal ions.  
 
The cytotoxicity data for all the compounds were used to construct QSAR model in 
an attempt to elucidate the relationship between structure and bioactivity. 
Satisfactory QSAR models were developed focusing on a few of the informative 
descriptors based on a wide set of relatively heterogeneous compounds as evidenced 
with value r2>0.6 and r2CV> 0.5.  
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Empat dithiokarbazat ligan yang baru [S-naftalen-2-ylmetilditiokarbazat (SNMDTC), 
S-kuinolin-2-ylmetil-ditiokarbazat (SQ2MDTC), S-benzil-N-benzilditiokarbazat 
(SBNBDTC) and S-metil-N-benzilditiokarbazat (SMNBDTC)], lapan siri bes Schiff 
yang berisomer berasal daripada berbagai S-gantian dithiokarbazat dengan kompleks 
logam telah berjaya disintesis dan dicirikan. Lapan belas struktur telah ditentukan 
dengan menggunakan pembelauan sinar-X. Sebatian baru telah direka secara 
sistematik sebelum disintesiskan bagi tujuan menghasilkan sebilangan sebatian yang 
berstruktur hetero-jenis untuk diaplikasikan dalam pengajian QSAR.  
 
Bes Schiff yang berasal daripada proses kondensasi dengan aldehid dan keton yang 
berisomer seperti, 3- dan 4-metilasetofenon dan 2-, 3- and 4-asetilpiridin dengan 
berbagai jenis sebatian gantian ditiokarbazat. Apabila pengkompleksan berlaku, 
semua bes Schiff membentuk bis-kelat (penderma NS) kompleks kecuali uninegatif 
 vi
tridentat S-naftalin-2ylmetil-β-N-(2-asetilpiridin)ditiokarbazat (SNM2AP) yang 
membentuk koordinasi dengan ion logam melalui azometin nitrogen atom, piridin 
nitrogen atom dan tiolo sulfur (penderma NNS). 
 
Sesetengah sebatian baru yang disintesiskan mempamerkan aktiviti yang signifikan 
terhadap patogen tertentu dan sitotoksik terhadap dua jenis sel barah payudara, sel 
barah payudara reseptor positif estrogen, MCF-7 dan sel barah payudara reseptor 
positif estrogen, MDA-MB-231. Aktiviti biologi untuk bes Schiff dan kompleksnya 
dinilai untuk menyiasat aktiviti paten. Kebanyakan kompleks telah dinilai lebih aktif 
berbanding dengan ligan asalnya selepas pengkomplekan dengan ion logam. 
 
Kesemua data sitotoksik sebatian telah dikumpulkan untuk membina model QSAR 
dengan harapan untuk mengilusidasi perhubungan di antara sturktur dan bioaktiviti. 
QSAR model yang memuaskan telah dibina yang memfokuskan beberapa diskriptor 
yang berinformasi berdasarkan kepada set yang mengandungi struktur hetero-jenis 
secara meluas berdasarkan nilai r2>0.6 dan r2CV> 0.5. 
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